BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Eric Linsley will participate on a panel titled "Leadership through Changing Times" at the Council for Entrepreneurial Development's Venture 2009 Conference in Pinehurst, NC
News | 04. 22. 2009
